ClearSign Technologies (CLIR) 10-Q 12 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 12, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Entity Registrant Name	CLEARSIGN COMBUSTION CORP
Entity Central Index Key	1,434,524
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CLIR
Entity Common Stock, Shares Outstanding		12,860,161

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 12,683,000	$ 1,845,000
Prepaid expenses	234,000	109,000
Total current assets	12,917,000	1,954,000
Fixed assets, net	148,000	263,000
Patents and other intangible assets, net	3,248,000	2,372,000
Other assets	10,000	10,000
Total Assets	16,323,000	4,599,000
Current Liabilities:
Accounts payable	370,000	253,000
Accrued compensation and taxes	970,000	982,000
Total current liabilities	1,340,000	1,235,000
Long Term Liabilities:
Long-term accrued compensation and taxes	91,000	372,000
Deferred rent	24,000	33,000
Total liabilities	$ 1,455,000	$ 1,640,000
Commitments
Stockholders' Equity:
Preferred stock, $0.0001 par value, zero shares issued and outstanding	$ 0	$ 0
Common stock, $0.0001 par value, 12,820,000 and 9,681,476 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	1,000	1,000
Additional paid-in capital	41,467,000	24,218,000
Accumulated deficit	(26,600,000)	(21,260,000)
Total stockholders' equity	14,868,000	2,959,000
Total Liabilities and Stockholders' Equity	$ 16,323,000	$ 4,599,000

Condensed Balance Sheets _Paren

Condensed Balance Sheets [Parenthetical] - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	12,820,000	9,681,476
Common stock, shares outstanding	12,820,000	9,681,476

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating expenses:
Research and development	$ 815,000	$ 673,000	$ 2,102,000	$ 1,836,000
General and administrative	1,154,000	1,049,000	3,269,000	3,162,000
Total operating expenses	1,969,000	1,722,000	5,371,000	4,998,000
Loss from operations	(1,969,000)	(1,722,000)	(5,371,000)	(4,998,000)
Other income:
Interest income	8,000	1,000	31,000	4,000
Net Loss	$ (1,961,000)	$ (1,721,000)	$ (5,340,000)	$ (4,994,000)
Net Loss per share - basic and fully diluted (in dollars per share)	$ (0.15)	$ (0.18)	$ (0.43)	$ (0.53)
Weighted average number of shares outstanding - basic and fully diluted (in shares)	12,811,313	9,657,092	12,330,082	9,451,929

Condensed Statement of Stockhol

Condensed Statement of Stockholders' Equity - 9 months ended Sep. 30, 2015 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balances at Dec. 31, 2014	$ 2,959,000	$ 1,000	$ 24,218,000	$ (21,260,000)
Balances (in shares) at Dec. 31, 2014		9,681,476
Shares issued in underwritten offering ($5.85 per share)	17,491,000	$ 0	17,491,000	0
Shares issued in underwritten offering ($5.85 per share) (in shares)		2,990,000
Issuance costs of underwritten offering	(1,212,000)	$ 0	(1,212,000)	0
Issuance costs of underwritten offering (in shares)		0
Shares issued for services ($5.97 per share)	100,000	$ 0	100,000	0
Shares issued for services ($5.97 per share) (in shares)		16,752
Shares issued for services ($3.96 per share)	10,000	$ 0	10,000	0
Shares issued for services ($3.96 per share) (in shares)		2,500
Shares issued upon exercise of options ($2.20 per share)	284,000	$ 0	284,000	0
Shares issued upon exercise of options ($2.20 per share) (in shares)		129,062
Shares issued upon exercise of options ($4.88 per share)	0	$ 0	0	0
Shares issued upon exercise of options ($4.88 per share) (in shares)		210
Share based compensation	576,000	$ 0	576,000	0
Share based compensation (in shares)		0
Net loss	(5,340,000)	$ 0	0	(5,340,000)
Balances at Sep. 30, 2015	$ 14,868,000	$ 1,000	$ 41,467,000	$ (26,600,000)
Balances (in shares) at Sep. 30, 2015		12,820,000

Condensed Statement of Stockho6

Condensed Statement of Stockholders' Equity [Parenthetical]	9 Months Ended
	Sep. 30, 2015$ / shares
Stock issued during the period underwritten offering per share	$ 5.85
Common stock for services per share issue	5.97
Common stock for services per share issue one	3.96
Stock issued during period par value exercise of options	2.20
Stock issued during period par value exercise of options one	$ 4.88

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (5,340,000)	$ (4,994,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for services	110,000	166,000
Share based payments	576,000	247,000
Depreciation and amortization	159,000	181,000
Abandonment of capitalized intangible assets	5,000	67,000
Deferred rent	(9,000)	5,000
Change in operating assets and liabilities:
Prepaid expenses	(125,000)	(31,000)
Accounts payable	117,000	25,000
Accrued compensation	(293,000)	41,000
Net cash used in operating activities	(4,800,000)	(4,293,000)
Cash flows from investing activities:
Acquisition of fixed assets	(37,000)	(77,000)
Disbursements for patents and other intangible assets	(888,000)	(880,000)
Net cash used in investing activities	(925,000)	(957,000)
Cash flows from financing activities:
Proceeds from issuance of common stock for cash, net of offering costs	16,279,000	5,780,000
Proceeds from exercise of stock options	284,000	59,000
Net cash provided by financing activities	16,563,000	5,839,000
Net increase in cash and cash equivalents	10,838,000	589,000
Cash and cash equivalents, beginning of period	1,845,000	2,688,000
Cash and cash equivalents, end of period	$ 12,683,000	$ 3,277,000

Supplemental disclosure of non-

Supplemental disclosure of non-cash operating and financing activities: - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
July 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	10,000
Shares Issued, Price Per Share	$ 2.20
Sale of Stock, Price Per Share	$ 8.93
Stock Issued During Period, Shares, Other	7,537
May 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	10,500
Shares Issued, Price Per Share	$ 4.88
Sale of Stock, Price Per Share	$ 4.98
Stock Issued During Period, Shares, Other	210
Common Stock Offering [Member]
Warrants Authorized For Issuance To Acquire Common Stock Shares Number		20,313
Warrants Authorized For Issuance To Acquire Common Stock Value		$ 92,000

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Organization, Consolidation, Basis Of Presentation, Business Description and Accounting Policies [Text Block]	Note 1 – Organization and Description of Business ClearSign Combustion Corporation (ClearSign or the Company) designs, develops and markets technologies for the purpose of improving key performance characteristics of combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. The Company’s primary technologies include its Duplex™ technology, which achieves very low emissions without the need of external flue gas recirculation, selective catalytic reduction, or higher excess air operation, and its Electrodynamic Combustion Control™ or ECC™ technology, which introduces a computer-controlled electric field into the combustion region which may better control gas-phase chemical reactions and improve system performance and cost-effectiveness. The Company is located in Seattle, Washington and was incorporated in the State of Washington in 2008. The Company has generated limited revenues from operations to date to meet its operating expenses, and has historically financed its operations primarily through issuances of equity securities. The Company has incurred losses since its inception totaling $ 26,600,000

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 – Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2014 has been derived from the Company’s audited financial statements. In the opinion of management, these financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These financial statements should be read in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. There were no revenues for the nine months . Cost of Revenue Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period. Cash and Cash Equivalents Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $ 250,000 Fixed Assets Fixed assets are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over two to four years. Maintenance and repairs are expensed as incurred. Patents and Trademarks Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are issued. Impairment of Long-Lived Assets The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value. Research and Development The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables used in laboratory and field testing. Deferred Rent Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheets. Income Taxes The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution. Stock-Based Compensation The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured. Net Loss per Common Share Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. At September 30, 2015 and 2014, potentially dilutive shares outstanding amounted to 1,365,647 1,241,115 Recently Issued Accounting Pronouncements Management does not believe that any recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements. Emerging Growth Company The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act). An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $ 700 61

Fixed Assets

Fixed Assets	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 3 – Fixed Assets September 30, December 31, 2015 2014 (unaudited) Machinery and equipment $ 650,000 $ 646,000 Office furniture and equipment 112,000 98,000 Leasehold improvements 130,000 124,000 Accumulated depreciation and amortization (744,000) (605,000) $ 148,000 $ 263,000

Patents and Other Intangible As

Patents and Other Intangible Assets	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 4 – Patents and Other Intangible Assets September 30, December 31, 2015 2014 (unaudited) Patents Patents pending $ 3,140,000 $ 2,262,000 Issued patents 67,000 67,000 3,207,000 2,329,000 Trademarks Trademarks pending 19,000 36,000 Registered trademarks 22,000 - 41,000 36,000 Other 8,000 8,000 3,256,000 2,373,000 Accumulated amortization (8,000) (1,000) $ 3,248,000 $ 2,372,000 2015 $ 2,000 2016 9,000 2017 9,000 2018 9,000 2019 9,000 Thereafter 43,000 $ 81,000 During the three and nine months ended September 30, 2015 and 2014, the Company recorded an impairment loss of $ 0 5,000 59,000 67,000

Termination of Employment Agree

Termination of Employment Agreement	9 Months Ended
	Sep. 30, 2015
Employment Agreement Termination [Abstract]
Termination of Employment Agreement Disclosure [Text Block]	Note 5 – Termination of Employment Agreement The Company and its former Chief Executive Officer, Richard F. Rutkowski, entered into an agreement in December 2014 terminating a prior employment agreement. Under this agreement, Mr. Rutkowski will be paid his annual salary of $ 359,000 60,000 15,625 4.88 14,219 9.90 The liability incurred under this agreement totaled $ 943,000 469,000

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 6 – Stockholders’ Equity Common Stock and Preferred Stock The Company is authorized to issue 62,500,000 2,000,000 In February 2015, the Company completed an underwritten public offering of common stock whereby 2,990,000 5.85 17.5 16.3 1.2 1,049,000 55,000 110,000 In March 2014, the Company completed a registered direct offering of common stock whereby 812,500 8.00 6.5 5.8 0.8 488,000 75,000 113,000 44,000 20,313 10.00 92,000 Equity Incentive Plan The Company has an Equity Incentive Plan (the Plan) which provides for the granting of options to purchase shares of common stock, stock awards to purchase shares at no less than 85 1,391,352 10 In the nine months ended September 30, 2015, the Company granted 407,200 300,000 3.96 5.97 10 1 2 4 1,236,000 923,000 The recognized compensation expense associated with these grants for the nine months ended September 30, 2015 was $ 404,000 Expected life 5.81 years Weighted average volatility 72% Forfeiture rate 11% Weighted average risk-free interest rate 1.46% Expected dividend rate - In February 2015, the Company authorized 23,034 5.97 138,000 38,000 100,000 38,000 In the nine months ended September 30, 2015, 129,062 2.20 210 4.88 285,000 Stock options may be exercised prior to vesting where the resulting shares of common stock are issued with a declining repurchase right in favor of the Company at the exercise price should the employee terminate employment or upon other related circumstances prior to the previous vesting date. At September 30, 2015, there are 5,003 4.88 Outstanding stock option grants at September 30, 2015 and December 31, 2014 totaled 801,375 643,817 322,599 441,958 207,176 190,424 16,000 28,000 0.0001 259,000 676,000 86,000 247,000 382,801 1,118,000 2 Consultant Stock Plan The Company has a 2013 Consultant Stock Plan (the Consultant Plan) which provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The number of shares reserved for issuance under the Consultant Plan on September 30, 2015 totaled 115,292 94,542 10,000 3.96 40,000 10,000 10,000 18,000 54,000 Warrants Total Outstanding Warrants Weighted Average Life Exercise Price Warrants Exercise Price (in years) $ 1.80 80,000 $ 1.80 5.39 $ 2.20 118,959 $ 2.20 0.61 $ 5.00 345,000 $ 5.00 1.57 $ 10.00 20,313 $ 10.00 3.43 564,272 $ 4.14

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 7 – Related Party Transactions In connection with the February 2015 underwritten public offering described in Note 6, the Company paid the underwriter, MDB Capital Group, LLC (MDB), underwriting fees of $ 1,049,000 55,000 8.1

Commitments

Commitments	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 8 – Commitments On February 3, 2015, the Company and its newly-appointed Chief Executive Officer, Stephen E. Pirnat entered into an employment agreement (the Agreement) which terminates on December 31, 2017 350,000 30 60 100,000 The Company has agreements with its three independent directors to compensate them annually. The obligation totals $ 300,000 150,000 The Company has a triple net lease for office and laboratory space through February 2017. Under the terms of the lease, the Company paid no rent for the period November 2011 to February 2012 and for February 2014. Rent escalates annually by 3 9,000 5,000 3,000 2015 $ 39,000 2016 151,000 2017 24,000 $ 214,000 For the three and nine months ended September 30, 2015 and 2014, rent expense amounted to $ 61,000 148,000 41,000 120,000 The Company has a field test agreement with a customer to demonstrate and test the Duplex technology in a once through steam generator (OTSG) used to facilitate a thermally enhanced oil recovery process. Under the terms of the agreement, the Company has retrofitted an OTSG unit in order to achieve certain performance criteria. The agreement also includes time-sensitive pricing, delivery and installation terms, if elected, that will apply to future purchases of this Duplex application by this customer.

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission for Form 10-Q. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. The condensed balance sheet at December 31, 2014 has been derived from the Company’s audited financial statements. In the opinion of management, these financial statements reflect all normal recurring and other adjustments necessary for a fair presentation. These financial statements should be read in conjunction with the audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year or any other future periods.
Use Of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known. There were no revenues for the nine months .
Cost of Sales, Policy [Policy Text Block]	Cost of Revenue Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $ 250,000
Fixed Assets Policy [Policy Text Block]	Fixed Assets Fixed assets are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over two to four years. Maintenance and repairs are expensed as incurred.
Patents and Trademarks Policy [Policy Text Block]	Patents and Trademarks Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are issued.
Impairment Of Long Lived Asset Policy [Policy Text Block]	Impairment of Long-Lived Assets The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal.
Fair Value Of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.
Research and Development Expense, Policy [Policy Text Block]	Research and Development The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables used in laboratory and field testing.
Deferred Rent Policy [Policy Text Block]	Deferred Rent Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheets.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.
Earnings Per Share, Policy [Policy Text Block]	Net Loss per Common Share Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. At September 30, 2015 and 2014, potentially dilutive shares outstanding amounted to 1,365,647 1,241,115
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements Management does not believe that any recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements.
Growing Company [Policy Text Block]	Emerging Growth Company The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act). An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $ 700 61

Fixed Assets (Tables)

Fixed Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Fixed assets are summarized as follows: September 30, December 31, 2015 2014 (unaudited) Machinery and equipment $ 650,000 $ 646,000 Office furniture and equipment 112,000 98,000 Leasehold improvements 130,000 124,000 Accumulated depreciation and amortization (744,000) (605,000) $ 148,000 $ 263,000

Patents and Other Intangible 19

Patents and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	Patents and other intangible assets are summarized as follows: September 30, December 31, 2015 2014 (unaudited) Patents Patents pending $ 3,140,000 $ 2,262,000 Issued patents 67,000 67,000 3,207,000 2,329,000 Trademarks Trademarks pending 19,000 36,000 Registered trademarks 22,000 - 41,000 36,000 Other 8,000 8,000 3,256,000 2,373,000 Accumulated amortization (8,000) (1,000) $ 3,248,000 $ 2,372,000
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2015 $ 2,000 2016 9,000 2017 9,000 2018 9,000 2019 9,000 Thereafter 43,000 $ 81,000

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2015
Schedule Of Recognized Compensation Cost [Table Text Block]	The Company has the following warrants outstanding at September 30, 2015: Total Outstanding Warrants Weighted Average Life Exercise Price Warrants Exercise Price (in years) $ 1.80 80,000 $ 1.80 5.39 $ 2.20 118,959 $ 2.20 0.61 $ 5.00 345,000 $ 5.00 1.57 $ 10.00 20,313 $ 10.00 3.43 564,272 $ 4.14
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options: Expected life 5.81 years Weighted average volatility 72% Forfeiture rate 11% Weighted average risk-free interest rate 1.46% Expected dividend rate -

Commitments (Tables)

Commitments (Tables)	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum future payments under this lease at September 30, 2015 are as follows: 2015 $ 39,000 2016 151,000 2017 24,000 $ 214,000

Organization and Description 22

Organization and Description of Business (Details Textual) - USD ($)	3 Months Ended		9 Months Ended		93 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015
Organization and Description of Business [Line Items]
Net loss	$ 1,961,000	$ 1,721,000	$ 5,340,000	$ 4,994,000	$ 26,600,000

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Variable Interest Entity [Line Items]
Cash, FDIC Insured Amount	$ 250,000
Weighted Average Number of Shares Outstanding, Diluted	1,365,647	1,241,115
Emerging Growth Company Minimum Revenue	$ 1,000,000,000
Emerging Growth Company Non Convertible Debt	1,000,000,000
Emerging Growth Company Minimum Non-Affiliate Market Value Of Common Stock	$ 700,000,000
Tax Benefits Recognized Description	The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
Emerging Growth Company Non-Affiliate Market Value Of Common Stock	$ 61,000,000
Property, Plant and Equipment, Estimated Useful Lives	over two to four years

Fixed Assets (Details)

Fixed Assets (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Machinery and equipment	$ 650,000	$ 646,000
Office furniture and equipment	112,000	98,000
Leasehold improvements	130,000	124,000
Accumulated depreciation	(744,000)	(605,000)
Property, Plant and Equipment, Net, Total	$ 148,000	$ 263,000

Patents and Other Intangible 25

Patents and Other Intangible Assets (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Patents	$ 3,207,000	$ 2,329,000
Trademarks	41,000	36,000
Other	8,000	8,000
Finite-Lived Intangible Assets, Gross	3,256,000	2,373,000
Accumulated amortization	(8,000)	(1,000)
Finite-Lived Intangible Assets, Net	3,248,000	2,372,000
Patents Pending [Member]
Patents	3,140,000	2,262,000
Issued Patents [Member]
Patents	67,000	67,000
Finite-Lived Intangible Assets, Net	81,000
Trademarks Pending [Member]
Trademarks	19,000	36,000
Registered Trademarks [Member]
Trademarks	$ 22,000	$ 0

Patents and Other Intangible 26

Patents and Other Intangible Assets (Details 1) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 3,248,000	$ 2,372,000
Issued Patents [Member]
Finite-Lived Intangible Assets [Line Items]
2,015	2,000
2,016	9,000
2,017	9,000
2,018	9,000
2,019	9,000
Thereafter	43,000
Finite-Lived Intangible Assets, Net	$ 81,000

Patents and Other Intangible 27

Patents and Other Intangible Assets (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Exploration Abandonment and Impairment Expense	$ 0	$ 59,000	$ 5,000	$ 67,000

Termination of Employment Agr28

Termination of Employment Agreement (Details Textual) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2016	Dec. 31, 2015
Financial Liabilities Fair Value Disclosure	$ 469,000
Richard F. Rutkowski [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	15,625
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$ 4.88
Richard F. Rutkowski [Member] | Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	14,219
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value	$ 9.90
Scenario, Forecast [Member] | Richard F. Rutkowski [Member]
Officers' Compensation		$ 359,000	$ 60,000
General and Administrative Expense [Member]
Financial Liabilities Fair Value Disclosure	$ 943,000

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Employee Stock Option [Member]	9 Months Ended
	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	5 years 9 months 22 days
Weighted average volatility	72.00%
Forfeiture rate	11.00%
Weighted average risk-free interest rate	1.46%
Expected dividend rate	0.00%

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1)	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Warrants Outstanding | shares	564,272
Warrants Outstanding Weighted Average Exercise Price	$ 4.14
Exercise Price 1.80 [Member]
Warrants Exercise Price	$ 1.80
Warrants Outstanding | shares	80,000
Warrants Outstanding Weighted Average Exercise Price	$ 1.80
Warrants Outstanding Remaining Life (in years)	5 years 4 months 20 days
Exercise Price 2.20 [Member]
Warrants Exercise Price	$ 2.20
Warrants Outstanding | shares	118,959
Warrants Outstanding Weighted Average Exercise Price	$ 2.20
Warrants Outstanding Remaining Life (in years)	7 months 10 days
Exercise Price 5.00 [Member]
Warrants Exercise Price	$ 5
Warrants Outstanding | shares	345,000
Warrants Outstanding Weighted Average Exercise Price	$ 5
Warrants Outstanding Remaining Life (in years)	1 year 6 months 25 days
Exercise Price 10.00 [Member]
Warrants Exercise Price	$ 10
Warrants Outstanding | shares	20,313
Warrants Outstanding Weighted Average Exercise Price	$ 10
Warrants Outstanding Remaining Life (in years)	3 years 5 months 5 days

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended			3 Months Ended			9 Months Ended		12 Months Ended
	Aug. 31, 2015	Feb. 28, 2015	Mar. 31, 2014	Dec. 31, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Sep. 30, 2016
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues							$ 17,491,000
Warrants Authorized For Issuance To Acquire Common Stock Shares Number			20,313
Common Stock, Shares Authorized					62,500,000		62,500,000
Preferred Stock, Shares Authorized					2,000,000		2,000,000
Share-Based Compensation							$ 576,000	$ 247,000
Proceeds From Issuance Or Sale Of Equity							$ 16,279,000	5,780,000
Stock Issued During Period Par Value Exercise Of Options							$ 2.20
Proceeds from Stock Options Exercised							$ 284,000	59,000
Registered Direct Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues			$ 6,500,000
Exercise Price Of Warrants			$ 10
Warrants Authorized For Issuance To Acquire Common Stock Value			$ 92,000
Stock Issued In Registered Direct Offering Price Per Share			$ 8
Placement Agent Fees			$ 488,000
Payments for Placement Agent Legal Fees			75,000
Other Cost and Expense, Operating			$ 44,000
Stock Issued During Period, Shares, Registered Direct Offering			812,500
Proceeds From Issuance Or Sale Of Equity			$ 5,800,000
Payment of Financing and Stock Issuance Costs			800,000
Underwritten Public Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, New Issues		$ 17,500,000
Other Cost and Expense, Operating		110,000
Proceeds From Issuance Or Sale Of Equity		16,300,000
Payment of Financing and Stock Issuance Costs		$ 1,200,000
Stock Issued During Period Shares Underwritten Public Offering		2,990,000
Stock Issued in Underwritten Public Offering Price Per Share		$ 5.85
Underwriter Agent fees		$ 1,049,000
Payments for Underwriter Agent Legal Fees		$ 55,000
Consultant Plan [Member]
Class of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance					115,292		115,292
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	10,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 3.96
Shares Reserved Unissued					94,542		94,542
Stock Granted During Period, Value, Share-Based Compensation, Gross	$ 40,000
Allocated Share-based Compensation Expense					$ 676,000	$ 247,000	$ 86,000
Consultant Plan Expenses					$ 10,000	10,000	$ 18,000	54,000
Equity Incentive Plan [Member]
Class of Stock [Line Items]
Common Stock, Shares Authorized		23,034
Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Share Minimum							85.00%
Common Stock, Capital Shares Reserved for Future Issuance					1,391,352		1,391,352
Increase Decrease Of Share Based Compensation Arrangement By Share Based Payment Award Percentage							10.00%
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan					801,375		801,375		643,817
Declining Repurchase Rights Per Share					$ 16,000		$ 16,000		$ 28,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized					$ 1,118,000		$ 1,118,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							207,176		190,424
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 5.97
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term							10 years
Share-Based Compensation					$ 259,000	$ 86,000	$ 676,000	$ 247,000
Shares Reserved Unissued					382,801		382,801
Selling, General and Administrative Expense, Total					$ 38,000		$ 100,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition							2 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number					322,599		322,599		441,958
Stock Granted During Period, Value, Share-Based Compensation, Gross							$ 1,236,000
Allocated Share-based Compensation Expense							$ 404,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							4 years
Share Based Compensation Arrangement by Share Based Payment Award Options Grants In Period Fair Value		$ 138,000
Stock Issued During Period Value One Stock Options Exercised							$ 210
Stock Issued During Period Shares One Stock Options Exercised							4.88
Stock Issued During Period Par Value Exercise Of Options							$ 2.20
Proceeds from Stock Options Exercised							$ 285,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period							129,062
Equity Incentive Plan [Member] | Minimum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value							$ 3.96
Equity Incentive Plan [Member] | Maximum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value							$ 5.97
Equity Incentive Plan [Member] | Subsequent Event [Member]
Class of Stock [Line Items]
Declining Repurchase Rights Value										$ 0.0001
Selling, General and Administrative Expense, Total				$ 38,000
Equity Incentive Plan [Member] | Employee Stock Option [Member]
Class of Stock [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Subject To Repurchase Rights Decline							5,003
Investment Options, Exercise Price							$ 4.88
Equity Incentive Plan [Member] | Chief Executive Officer [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							300,000
Stock Granted During Period, Value, Share-Based Compensation, Gross							$ 923,000
Equity Incentive Plan [Member] | Chief Executive Officer [Member] | Minimum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							1 year
Equity Incentive Plan [Member] | Chief Executive Officer [Member] | Maximum [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							2 years
Equity Incentive Plan [Member] | Employees and Consultant [Member]
Class of Stock [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross							407,200
Legal Fees [Member] | Registered Direct Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Issued for Noncash Considerations			$ 113,000

Related Party Transactions (Det

Related Party Transactions (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Mar. 31, 2015
MDB Consulting Services [Member]
Related Party Transaction [Line Items]
Payments for Underwriting Expense	$ 1,049,000
Other Underwriting Expense	$ 55,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage		8.10%

Commitments (Details)

Commitments (Details)	Sep. 30, 2015USD ($)
Operating Leased Assets [Line Items]
2,015	$ 39,000
2,016	151,000
2,017	24,000
Operating Leases, Future Minimum Payments Due	$ 214,000

Commitments (Details Textual)

Commitments (Details Textual) - USD ($)	Feb. 03, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Loss Contingencies [Line Items]
Rent Expense Escalation Percentage				3.00%
Reduction In Deferred Rent				$ 9,000
Operating Leases, Rent Expense		$ 61,000	$ 41,000	148,000	$ 120,000
Contractual Obligation		300,000		300,000
Obligation To Pay In Common Stock At Fair Value		$ 150,000		150,000
Triple Net Operating Cost				$ 3,000
Accrued Rent			$ 5,000		$ 5,000
Minimum [Member]
Loss Contingencies [Line Items]
Annual Cash Bonus	30.00%
Maximum [Member]
Loss Contingencies [Line Items]
Annual Cash Bonus	60.00%
Stephen E. Pirnat [Member]
Loss Contingencies [Line Items]
Salaries, Wages and Officers' Compensation	$ 350,000
Employment Agreement Termination Date	Dec. 31, 2017
Labor and Related Expense	$ 100,000